Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction

Neuroscience Letters

Volumn 417, Issue 3, 2007, Pages 255-260

  Wang, Fang ^a   Liang, Zhijian ^a   Hou, Qinghua ^a   Xing, Shihui ^a   Ling, Li ^a   He, Meixia ^a   Pei, Zhong ^a   Zeng, Jinsheng ^a  

^a First Affiliated Hospital   (China)

Author keywords

Cerebral infarction; NEP1 40; Nogo A; Rats; Secondary degeneration

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NEP1 40; NEUROMODULIN; NOGO 66 RECEPTOR; PROTEIN NOGO A; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTINUOUS INFUSION; CONTROLLED STUDY; DENDRITE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; THALAMUS VENTRAL NUCLEUS;

ANIMALS; AXONS; BIOLOGICAL MARKERS; CEREBRAL INFARCTION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MYELIN PROTEINS; NERVE GROWTH FACTORS; NERVE REGENERATION; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RETROGRADE DEGENERATION; THALAMUS; UP-REGULATION; VENTRAL THALAMIC NUCLEI; WALLERIAN DEGENERATION;

EID: 34247106693     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.02.080     Document Type: Article

References (18)

1. Bareyre F.M., Haudenschild B., and Schwab M.E. Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J. Neurosci. 22 (2002) 7097-7110
2. Brint S., Jacewicz M., Kiessling M., Tanabe J., and Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J. Cereb. Blood Flow Metab. 8 (1988) 474-485
3. Chu W.J., Mason G.F., Pan J.W., Hetherington H.P., Liu H.G., San Pedro E.C., and Mountz J.M. Regional cerebral blood flow and magnetic resonance spectroscopic imaging findings in diaschisis from stroke. Stroke 33 (2002) 1243-1248
4. Dihne M., Grommes C., Lutzenburg M., Witte O.W., and Block F. Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke 33 (2002) 3006-3011
5. Fournier A.E., Gould G.C., Liu B.P., and Strittmatter S.M. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J. Neurosci. 22 (2002) 8876-8883
6. Grados-Munro E.M., and Fournier A.E. Myelin-associated inhibitors of axon regeneration. J. Neurosci. Res. 74 (2003) 479-485
7. GrandPre T., Li S., and Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417 (2002) 547-551
8. Huber A.B., Weinmann O., Brosamle C., Oertle T., and Schwab M.E. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22 (2002) 3553-3567
9. Imai H., McCulloch J., Graham D.I., Masayasu H., and Macrae I.M. New method for the quantitative assessment of axonal damage in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 22 (2002) 1080-1089
10. Karnezis T., Mandemakers W., McQualter J.L., Zheng B., Ho P.P., Jordan K.A., Murray B.M., Barres B., Tessier-Lavigne M., and Bernard C.C. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 7 (2004) 736-744
11. Kawamata T., Speliotes E.K., and Finklestein S.P. The role of polypeptide growth factors in recovery from stroke. Adv. Neurol. 739 (1997) 377-382
12. Li Y., Jiang N., Powers C., and Chopp M. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 29 (1998) 1972-1980
13. Papadopoulos C.M., Tsai S.Y., Alsbiei T., O'Brien T.E., Schwab M.E., and Kartje G.L. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann. Neurol. 51 (2002) 433-434
14. Tamura A., Tahira Y., Nagashima H., Kirino T., Gotoh O., Hojo S., and Sano K. Thalamic atrophy following cerebral infarction in the territory of the middle cerebral artery. Stroke 22 (1991) 615-618
15. Van Groen T., Puurunen K., Maki H.M., Sivenius J., and Jolkkonen J. Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 36 (2005) 1551-1556
16. Weinmann O., Schnell L., Ghosh A., Montani L., Wiessner C., Wannier T., Rouiller E., Mir A., and Schwab M.E. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A. J. Neurosci. 18 (1998) 10429-10437
17. Zeng J., Zhang Y., Mo J., Su Z., and Huang R. Two-kidney, two clip renovascular hypertensive rats can be used as stroke-prone rats. Stroke 29 (1998) 1708-1713
18. Zhou C., Li Y., Nanda A., and Zhang J.H. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem. Biophys. Res. Commun. 309 (2003) 368-376